GOLDSTEIN GIDEON has a total of 13 patent applications. Its first patent ever was published in 1975. It filed its patents most often in United States, Canada and EPO (European Patent Office). Its main competitors in its focus markets machines, biotechnology and pharmaceuticals are INTRACEL CORP, CUBICCIOTTI ROGER S and ROCHE DIAGNOSTIC SYSTEMS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 5 | |
#2 | Canada | 4 | |
#3 | EPO (European Patent Office) | 3 | |
#4 | Australia | 1 |
# | Industry | |
---|---|---|
#1 | Machines | |
#2 | Biotechnology | |
#3 | Pharmaceuticals | |
#4 | Measurement |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Unspecified technologies | |
#3 | Analysing materials | |
#4 | Medical preparations | |
#5 | Unspecified technologies | |
#6 | Microorganisms | |
#7 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Goldstein Gideon | 13 |
#2 | Culler Michael D | 8 |
#3 | Shenbagamurthi Ponniah | 3 |
#4 | Audhya Tapan | 1 |
#5 | Koenig James I | 1 |
#6 | Schlesinger David H | 1 |
Publication | Filing date | Title |
---|---|---|
EP0767678A1 | Compositions of transactivating proteins of human immunodeficiency virus | |
US5593842A | Method of measuring thymopoietin proteins in plasma and serum including acidification of the plasma and serum | |
US5591588A | Method for the diagnosis of depression based on monitoring blood levels of arginine vasopressin and/or thymopoietin | |
CA2041183A1 | Human and rat thymopoietin | |
US4002602A | Ubiquitous immunopoietic polypeptide (UBIP) and methods | |
US4002740A | Tridecapeptide compositions and methods |